Dow Up 0.15% Nasdaq Up 0.21%

Novo Nordisk A/S (NVO)

-NYSE
48.47 0.72(1.51%) Sep 17, 4:03PM EDT
|After Hours : 48.48 Up 0.01 (0.02%) Sep 17, 5:46PM EDT
Prev Close:47.75
Open:48.23
Bid:46.00 x 100
Ask:50.00 x 500
1y Target Est:49.37
Beta:1.04
Next Earnings Date:N/A
Day's Range:48.08 - 48.60
52wk Range:32.55 - 48.60
Volume:1,311,207
Avg Vol (3m):910,302
Market Cap:127.42B
P/E (ttm):27.89
EPS (ttm):1.74
Div & Yield:0.61 (1.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVOUp 1.51%127.42B
LLY70.64B
PFE192.45B
SNY148.32B

Key Statistics

Forward P/E (1 yr):24.24
P/S (ttm):8.57
Ex-Dividend Date:21-Mar-14

Analysts

Annual EPS Est (Dec-14) :1.78
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback